HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals
One drug manufacturer has agreed to pay $10 million to resolve its part in allegations that Gilead and other drug makers conspired to keep HIV medication prices artificially high.